Skip to main content
. 2023 Jan 26;13:1460. doi: 10.1038/s41598-023-28797-5

Figure 1.

Figure 1

Systemic values and ratios of innate immunity cytokines. According to the disease severity, all Coronavirus disease 2019 (COVID-19) patients were divided in four groups (stage I (n = 61), II (n = 69), III (n = 54), IV (n = 48)). Systemic values of tumor necrosis factor α (TNF-α), interleukin (IL) 1β, IL-12, IL-10, and Galectin-3 were determined by ELISA. The ratios of IL-10/IL-1β, IL-10/TNF-α, IL-10/IL-12 as well as Gal-3/IL-1β, Gal-3/TNF-α and Gal-3/IL-12 were evaluated for each patient, separately. For statistical significance determination, Kruskal–Wallis test, with post hoc Mann–Whitney Rank Sum test, was used. *p < 0.05.